Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered Janssen to pay $1.64 billion after a jury found it liable in a whistleblower lawsuit for illegally promoting Prezista and Intelence.
You are not logged in so some information on this page has been withheld. To see more, please log in.